Cyclin H Antibody (3G6) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59440APC
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 3G6
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Cyclin H Antibody (3G6) [Allophycocyanin]
Immunogen
Recombinant human Cyclin H (1-323aa) purified from E.coli
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for Cyclin H Antibody (3G6) [Allophycocyanin]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cyclin H
Alternate Names
CAK, cyclin H, cyclin-dependent kinase-activating kinase complex subunit, cyclin-H, MO15-associated protein, p34CAK complex subunit, p37CDK-activating kinase complex subunit
Gene Symbol
CCNH
Additional Cyclin H Products
Product Documents for Cyclin H Antibody (3G6) [Allophycocyanin]
Product Specific Notices for Cyclin H Antibody (3G6) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...